Add-on Acquisition • Chemicals

eMolecules Acquires Synple

On September 24, 2024, eMolecules acquired chemicals company Synple

Acquisition Context

This is eMolecules’ 1st transaction in the Chemicals sector.
This is eMolecules’ 1st transaction in Switzerland.

Explore All 1513 Add-on Acquisition Chemicals Deals - Search the Database Free

M&A Deal Summary
Date	September 24, 2024
Target	Synple
Sector	Chemicals
Buyer(s)	eMolecules
Deal Type	Add-on Acquisition

Target Company

Synple

Kemptthal, Switzerland

Synple specializes in automated chemical synthesis systems and solutions for small molecules drug discovery customers. Synple was formed in 2016 and is headquartered in Kemptthal, Switzerland.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

eMolecules

San Diego, California, United States

Category	Company
Founded	2005
Sector	Software

DESCRIPTION

eMolecules provides business intelligence data and integrated ecommerce software for screening compound, chemical building blocks and primary antibody supply chains. eMolecules was founded in 2005 and is based in San Diego, California.

Deal Context for Buyer	#
Overall	4 of 4
Sector: Chemicals	1 of 1
Type: Add-on Acquisition	4 of 4
Country: Switzerland	1 of 1
Year: 2024	1 of 1

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2023-05-25	Specs Zoetermeer, Netherlands Specs offers chemical compound management services to the life sciences industry, particularly in the European pharmaceutical, biotechnology and academic sectors, driving time and cost efficiencies for customers' large scale drug candidate screening programs. Specs was founded in 1987 and is based in Zoetermeer, Netherlands.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2023-05-25

Specs

Zoetermeer, Netherlands

Specs offers chemical compound management services to the life sciences industry, particularly in the European pharmaceutical, biotechnology and academic sectors, driving time and cost efficiencies for customers' large scale drug candidate screening programs. Specs was founded in 1987 and is based in Zoetermeer, Netherlands.

Buy

Explore Related M&A Activity

Chemicals M&A - Add-on Acquisition M&A Deals - Switzerland M&A - 2024 M&A